Genetics in pulmonary arterial hypertension in a large homogeneous Japanese population

S. Gamou, Masaharu Kataoka, Y. Aimi, T. Chiba, Y. Momose, S. Isobe, T. Hirayama, H. Yoshino, Keiichi Fukuda, T. Satoh

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Pulmonary arterial hypertension (PAH) is a rare but serious disease with a grave prognosis. Bone morphogenetic protein type 2 receptor (BMPR2) gene is a strong pathogenic factor for PAH. As a collaborative team from Kyorin University and Keio University in Japan, we have analyzed the BMPR2 gene in 356 probands and more than 50 family members, including secondary patients. Importantly, the study population is a racially, ethnically, and socially homogeneous population. In PAH patients, there is a high incidence of unique mutations in BMPR2, and several mutations are frequently observed in the Japanese population, suggesting that these common and recurring mutations may be highly pathogenic or have high penetrance, explaining why they are found frequently throughout the world. We have also mapped each breakpoint of exonic deletions/duplications and found that most break and rejoining points are in the Alu elements. Reviewing the distribution of the reported mutations on each exon of BMPR2 revealed that the number and frequency of mutations are imbalanced among exons. The penetrance of BMPR2 gene mutations was 3-fold higher in females than males. Full elucidation of BMPR2-mediated pathogenic mechanisms in PAH requires persistent efforts to achieve precision or individualized medicine as a therapeutic strategy for PAH.

Original languageEnglish
JournalClinical Genetics
DOIs
Publication statusAccepted/In press - 2018 Jan 1

Fingerprint

Type II Bone Morphogenetic Protein Receptors
Pulmonary Hypertension
Mutation
Population
Precision Medicine
Penetrance
Exons
Alu Elements
Genes
Mutation Rate
Rare Diseases
Japan
Incidence

Keywords

  • BMPR2 gene
  • Copy number variation
  • Dominant negative
  • Exonic deletion
  • Genetic anticipation
  • Haplo-insufficiency
  • Mutation
  • Penetrance
  • Pulmonary arterial hypertension

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Gamou, S., Kataoka, M., Aimi, Y., Chiba, T., Momose, Y., Isobe, S., ... Satoh, T. (Accepted/In press). Genetics in pulmonary arterial hypertension in a large homogeneous Japanese population. Clinical Genetics. https://doi.org/10.1111/cge.13154

Genetics in pulmonary arterial hypertension in a large homogeneous Japanese population. / Gamou, S.; Kataoka, Masaharu; Aimi, Y.; Chiba, T.; Momose, Y.; Isobe, S.; Hirayama, T.; Yoshino, H.; Fukuda, Keiichi; Satoh, T.

In: Clinical Genetics, 01.01.2018.

Research output: Contribution to journalArticle

Gamou, S, Kataoka, M, Aimi, Y, Chiba, T, Momose, Y, Isobe, S, Hirayama, T, Yoshino, H, Fukuda, K & Satoh, T 2018, 'Genetics in pulmonary arterial hypertension in a large homogeneous Japanese population', Clinical Genetics. https://doi.org/10.1111/cge.13154
Gamou, S. ; Kataoka, Masaharu ; Aimi, Y. ; Chiba, T. ; Momose, Y. ; Isobe, S. ; Hirayama, T. ; Yoshino, H. ; Fukuda, Keiichi ; Satoh, T. / Genetics in pulmonary arterial hypertension in a large homogeneous Japanese population. In: Clinical Genetics. 2018.
@article{72d181c72aad49c4b8245c7372e5a51a,
title = "Genetics in pulmonary arterial hypertension in a large homogeneous Japanese population",
abstract = "Pulmonary arterial hypertension (PAH) is a rare but serious disease with a grave prognosis. Bone morphogenetic protein type 2 receptor (BMPR2) gene is a strong pathogenic factor for PAH. As a collaborative team from Kyorin University and Keio University in Japan, we have analyzed the BMPR2 gene in 356 probands and more than 50 family members, including secondary patients. Importantly, the study population is a racially, ethnically, and socially homogeneous population. In PAH patients, there is a high incidence of unique mutations in BMPR2, and several mutations are frequently observed in the Japanese population, suggesting that these common and recurring mutations may be highly pathogenic or have high penetrance, explaining why they are found frequently throughout the world. We have also mapped each breakpoint of exonic deletions/duplications and found that most break and rejoining points are in the Alu elements. Reviewing the distribution of the reported mutations on each exon of BMPR2 revealed that the number and frequency of mutations are imbalanced among exons. The penetrance of BMPR2 gene mutations was 3-fold higher in females than males. Full elucidation of BMPR2-mediated pathogenic mechanisms in PAH requires persistent efforts to achieve precision or individualized medicine as a therapeutic strategy for PAH.",
keywords = "BMPR2 gene, Copy number variation, Dominant negative, Exonic deletion, Genetic anticipation, Haplo-insufficiency, Mutation, Penetrance, Pulmonary arterial hypertension",
author = "S. Gamou and Masaharu Kataoka and Y. Aimi and T. Chiba and Y. Momose and S. Isobe and T. Hirayama and H. Yoshino and Keiichi Fukuda and T. Satoh",
year = "2018",
month = "1",
day = "1",
doi = "10.1111/cge.13154",
language = "English",
journal = "Clinical Genetics",
issn = "0009-9163",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Genetics in pulmonary arterial hypertension in a large homogeneous Japanese population

AU - Gamou, S.

AU - Kataoka, Masaharu

AU - Aimi, Y.

AU - Chiba, T.

AU - Momose, Y.

AU - Isobe, S.

AU - Hirayama, T.

AU - Yoshino, H.

AU - Fukuda, Keiichi

AU - Satoh, T.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Pulmonary arterial hypertension (PAH) is a rare but serious disease with a grave prognosis. Bone morphogenetic protein type 2 receptor (BMPR2) gene is a strong pathogenic factor for PAH. As a collaborative team from Kyorin University and Keio University in Japan, we have analyzed the BMPR2 gene in 356 probands and more than 50 family members, including secondary patients. Importantly, the study population is a racially, ethnically, and socially homogeneous population. In PAH patients, there is a high incidence of unique mutations in BMPR2, and several mutations are frequently observed in the Japanese population, suggesting that these common and recurring mutations may be highly pathogenic or have high penetrance, explaining why they are found frequently throughout the world. We have also mapped each breakpoint of exonic deletions/duplications and found that most break and rejoining points are in the Alu elements. Reviewing the distribution of the reported mutations on each exon of BMPR2 revealed that the number and frequency of mutations are imbalanced among exons. The penetrance of BMPR2 gene mutations was 3-fold higher in females than males. Full elucidation of BMPR2-mediated pathogenic mechanisms in PAH requires persistent efforts to achieve precision or individualized medicine as a therapeutic strategy for PAH.

AB - Pulmonary arterial hypertension (PAH) is a rare but serious disease with a grave prognosis. Bone morphogenetic protein type 2 receptor (BMPR2) gene is a strong pathogenic factor for PAH. As a collaborative team from Kyorin University and Keio University in Japan, we have analyzed the BMPR2 gene in 356 probands and more than 50 family members, including secondary patients. Importantly, the study population is a racially, ethnically, and socially homogeneous population. In PAH patients, there is a high incidence of unique mutations in BMPR2, and several mutations are frequently observed in the Japanese population, suggesting that these common and recurring mutations may be highly pathogenic or have high penetrance, explaining why they are found frequently throughout the world. We have also mapped each breakpoint of exonic deletions/duplications and found that most break and rejoining points are in the Alu elements. Reviewing the distribution of the reported mutations on each exon of BMPR2 revealed that the number and frequency of mutations are imbalanced among exons. The penetrance of BMPR2 gene mutations was 3-fold higher in females than males. Full elucidation of BMPR2-mediated pathogenic mechanisms in PAH requires persistent efforts to achieve precision or individualized medicine as a therapeutic strategy for PAH.

KW - BMPR2 gene

KW - Copy number variation

KW - Dominant negative

KW - Exonic deletion

KW - Genetic anticipation

KW - Haplo-insufficiency

KW - Mutation

KW - Penetrance

KW - Pulmonary arterial hypertension

UR - http://www.scopus.com/inward/record.url?scp=85041037929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041037929&partnerID=8YFLogxK

U2 - 10.1111/cge.13154

DO - 10.1111/cge.13154

M3 - Article

AN - SCOPUS:85041037929

JO - Clinical Genetics

JF - Clinical Genetics

SN - 0009-9163

ER -